Advertisement
AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


AJPH First Look, published online ahead of print May 29, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
AJPH.2007.118505v1
98/7/1248    most recent
Right arrow Submit a response
Right arrow purchase articles
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Get other permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Theppeang, K.
Right arrow Articles by Schwartz, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Theppeang, K.
Right arrow Articles by Schwartz, B. S.
Related Collections
Right arrow Aging
Right arrow Epidemiology
Right arrow African Americans/Blacks
Right arrow Socioeconomic Factors
Right arrow Urban Health
Right arrow Lead
July 2008, Vol 98, No. 7 | American Journal of Public Health 1248-1255
© 2008 American Public Health Association
DOI: 10.2105/AJPH.2007.118505


RESEARCH AND PRACTICE

Gender and Race/Ethnicity Differences in Lead Dose Biomarkers

Keson Theppeang, MHS, Thomas A. Glass, PhD, Karen Bandeen-Roche, PhD, Andrew C. Todd, PhD, Charles A. Rohde, PhD and Brian S. Schwartz, MD

Keson Theppeang and Brian S. Schwartz are with the Department of Environmental Health Sciences, Division of Occupational and Environmental Health; Thomas A. Glass and Brian S. Schwartz are with the Department of Epidemiology; and Keson Theppeang, Karen Bandeen-Roche, and Charles A. Rohde are with the Department of Biostatistics, all at the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Andrew C. Todd is with the Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, NY.

Correspondence: Requests for reprints should be sent to Brian S. Schwartz, Johns Hopkins University, Bloomberg School of Public Health, 615 North Wolfe St, Room W7041, Baltimore, MD 21205 (e-mail: bschwart{at}jhsph.edu).

Objectives. We sought to identify predictors of lead concentrations in the blood, tibias, and patellae of older adults and to describe differences by gender, race/ethnicity, and other factors that can influence lead toxicokinetics and, thus modify health effects.

Methods. Participants aged 50 to 70 years (N=1140) were randomly identified from selected neighborhoods in Baltimore, Maryland. We measured lead concentrations by anodic stripping voltammetry (in blood) and 109Cd-induced K-shell x-ray fluorescence (in bone). We used multiple linear regression to identify predictors of lead concentrations.

Results. Mean (SD) lead concentrations in blood, tibias, and patellae were 3.5 (2.4) µg/dL, 18.9 (12.5) µg/g, and 6.8 (18.1) µg/g, respectively. Tibia concentrations were 29% higher in African Americans than in Whites (P < .01). We observed effect modification by race/ethnicity on the association of gender and physical activity to blood lead concentrations and by gender on the association of age to tibia lead concentrations. Patella lead concentrations differed by gender; apolipoprotein E genotype modified this relation.

Conclusions. African Americans evidenced a prominent disparity in lifetime lead dose. Women may be at higher risk of release of lead from bone and consequent health effects because of increased bone demineralization with aging.




This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
M. F. Bouchard, D. C. Bellinger, J. Weuve, J. Matthews-Bellinger, S. E. Gilman, R. O. Wright, J. Schwartz, and M. G. Weisskopf
Blood Lead Levels and Major Depressive Disorder, Panic Disorder, and Generalized Anxiety Disorder in US Young Adults
Arch Gen Psychiatry, December 1, 2009; 66(12): 1313 - 1319.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
T. A. Glass, K. Bandeen-Roche, M. McAtee, K. Bolla, A. C. Todd, and B. S. Schwartz
Neighborhood Psychosocial Hazards and the Association of Cumulative Lead Dose With Cognitive Function in Older Adults
Am. J. Epidemiol., March 15, 2009; 169(6): 683 - 692.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Public Health Association